Form 20FR12B/A - Registration of securities [Section 12(b)]: [Amend]
SEC Accession No. 0001140361-24-044557
Filing Date
2024-10-30
Accepted
2024-10-29 19:03:54
Documents
3

Document Format Files

Seq Description Document Type Size
1 20FR12B/A ny20034211x5_20fr12ba.htm 20FR12B/A 7803451
2 EXHIBIT 15.1 ny20034211x5_ex15-1.htm EX-15.1 1797
3 ny20034211x5_linechart01.jpg GRAPHIC 417160
  Complete submission text file 0001140361-24-044557.txt   8380578
Mailing Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051
Business Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 61 3 9093 3855
Telix Pharmaceuticals Ltd (Filer) CIK: 0002007191 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: 20FR12B/A | Act: 34 | File No.: 001-42128 | Film No.: 241407037
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)